199 related articles for article (PubMed ID: 12751635)
1. Large porous particle impingement on lung epithelial cell monolayers--toward improved particle characterization in the lung.
Fiegel J; Ehrhardt C; Schaefer UF; Lehr CM; Hanes J
Pharm Res; 2003 May; 20(5):788-96. PubMed ID: 12751635
[TBL] [Abstract][Full Text] [Related]
2. Culture of Calu-3 cells at the air interface provides a representative model of the airway epithelial barrier.
Grainger CI; Greenwell LL; Lockley DJ; Martin GP; Forbes B
Pharm Res; 2006 Jul; 23(7):1482-90. PubMed ID: 16779708
[TBL] [Abstract][Full Text] [Related]
3. Drug transport across pulmonary epithelial cell monolayers: effects of particle size, apical liquid volume, and deposition technique.
Bur M; Huwer H; Muys L; Lehr CM
J Aerosol Med Pulm Drug Deliv; 2010 Jun; 23(3):119-27. PubMed ID: 20073555
[TBL] [Abstract][Full Text] [Related]
4. Calu-3 cells grown under AIC and LCC conditions: implications for dipeptide uptake and transepithelial transport of substances.
Stentebjerg-Andersen A; Notlevsen IV; Brodin B; Nielsen CU
Eur J Pharm Biopharm; 2011 May; 78(1):19-26. PubMed ID: 21195173
[TBL] [Abstract][Full Text] [Related]
5. Modelling the bronchial barrier in pulmonary drug delivery: A human bronchial epithelial cell line supplemented with human tracheal mucus.
Murgia X; Yasar H; Carvalho-Wodarz C; Loretz B; Gordon S; Schwarzkopf K; Schaefer U; Lehr CM
Eur J Pharm Biopharm; 2017 Sep; 118():79-88. PubMed ID: 28373109
[TBL] [Abstract][Full Text] [Related]
6. The permeability of large molecular weight solutes following particle delivery to air-interfaced cells that model the respiratory mucosa.
Grainger CI; Greenwell LL; Martin GP; Forbes B
Eur J Pharm Biopharm; 2009 Feb; 71(2):318-24. PubMed ID: 18845252
[TBL] [Abstract][Full Text] [Related]
7. Efficient bioactive delivery of aerosolized drugs to human pulmonary epithelial cells cultured in air-liquid interface conditions.
Lenz AG; Stoeger T; Cei D; Schmidmeir M; Semren N; Burgstaller G; Lentner B; Eickelberg O; Meiners S; Schmid O
Am J Respir Cell Mol Biol; 2014 Oct; 51(4):526-35. PubMed ID: 24773184
[TBL] [Abstract][Full Text] [Related]
8. Development of three-dimensional lung multicellular spheroids in air- and liquid-interface culture for the evaluation of anticancer therapeutics.
Meenach SA; Tsoras AN; McGarry RC; Mansour HM; Hilt JZ; Anderson KW
Int J Oncol; 2016 Apr; 48(4):1701-9. PubMed ID: 26846376
[TBL] [Abstract][Full Text] [Related]
9. Alteration in Intrapulmonary Pharmacokinetics of Aerosolized Model Compounds Due to Disruption of the Alveolar Epithelial Barriers Following Bleomycin-Induced Pulmonary Fibrosis in Rats.
Togami K; Chono S; Tada H
J Pharm Sci; 2016 Mar; 105(3):1327-34. PubMed ID: 26886341
[TBL] [Abstract][Full Text] [Related]
10. Cellular mechanisms of mainstream cigarette smoke-induced lung epithelial tight junction permeability changes in vitro.
Olivera DS; Boggs SE; Beenhouwer C; Aden J; Knall C
Inhal Toxicol; 2007 Jan; 19(1):13-22. PubMed ID: 17127639
[TBL] [Abstract][Full Text] [Related]
11. Influence of apical fluid volume on the development of functional intercellular junctions in the human epithelial cell line 16HBE14o-: implications for the use of this cell line as an in vitro model for bronchial drug absorption studies.
Ehrhardt C; Kneuer C; Fiegel J; Hanes J; Schaefer UF; Kim KJ; Lehr CM
Cell Tissue Res; 2002 Jun; 308(3):391-400. PubMed ID: 12107432
[TBL] [Abstract][Full Text] [Related]
12. The cell line NCl-H441 is a useful in vitro model for transport studies of human distal lung epithelial barrier.
Salomon JJ; Muchitsch VE; Gausterer JC; Schwagerus E; Huwer H; Daum N; Lehr CM; Ehrhardt C
Mol Pharm; 2014 Mar; 11(3):995-1006. PubMed ID: 24524365
[TBL] [Abstract][Full Text] [Related]
13. Development of a size-dependent aerosol deposition model utilising human airway epithelial cells for evaluating aerosol drug delivery.
Cooney D; Kazantseva M; Hickey AJ
Altern Lab Anim; 2004 Dec; 32(6):581-90. PubMed ID: 15757496
[TBL] [Abstract][Full Text] [Related]
14. Insulin aggregation and asymmetric transport across human bronchial epithelial cell monolayers (Calu-3).
Pezron I; Mitra R; Pal D; Mitra AK
J Pharm Sci; 2002 Apr; 91(4):1135-46. PubMed ID: 11948552
[TBL] [Abstract][Full Text] [Related]
15. Calu-3 model under AIC and LCC conditions and application for protein permeability studies.
Marušić M; Djurdjevič I; Drašlar K; Caserman S
Acta Chim Slov; 2014; 61(1):100-9. PubMed ID: 24664333
[TBL] [Abstract][Full Text] [Related]
16. A new Pharmaceutical Aerosol Deposition Device on Cell Cultures (PADDOCC) to evaluate pulmonary drug absorption for metered dose dry powder formulations.
Hein S; Bur M; Schaefer UF; Lehr CM
Eur J Pharm Biopharm; 2011 Jan; 77(1):132-8. PubMed ID: 20951200
[TBL] [Abstract][Full Text] [Related]
17. Inhalable, bioresponsive microparticles for targeted drug delivery in the lungs.
Sivadas N; Cryan SA
J Pharm Pharmacol; 2011 Mar; 63(3):369-75. PubMed ID: 21749384
[TBL] [Abstract][Full Text] [Related]
18. The interaction of dendrimer-doxorubicin conjugates with a model pulmonary epithelium and their cosolvent-free, pseudo-solution formulations in pressurized metered-dose inhalers.
Zhong Q; Humia BV; Punjabi AR; Padilha FF; da Rocha SRP
Eur J Pharm Sci; 2017 Nov; 109():86-95. PubMed ID: 28774811
[TBL] [Abstract][Full Text] [Related]
19. Permeability characteristics of calu-3 human bronchial epithelial cells: in vitro-in vivo correlation to predict lung absorption in rats.
Mathia NR; Timoszyk J; Stetsko PI; Megill JR; Smith RL; Wall DA
J Drug Target; 2002 Feb; 10(1):31-40. PubMed ID: 11996084
[TBL] [Abstract][Full Text] [Related]
20. Steroid/mucokinetic hybrid nanoporous microparticles for pulmonary drug delivery.
Tewes F; Paluch KJ; Tajber L; Gulati K; Kalantri D; Ehrhardt C; Healy AM
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):604-13. PubMed ID: 23563102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
